Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6W9V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,762
Award facts
- Contract value 100% obligated
- $6,762.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,762.36 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 vehicle that extends through December 2026 and serves as the primary pharmaceutical supply mechanism for military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities, veterans' healthcare systems, and other federal medical institutions. RINVOQ (upadacitinib) is a Janus kinase inhibitor used for treating rheumatoid arthritis and other autoimmune conditions, reflecting the broad spectrum of pharmaceutical products the contractor delivers through its DLA relationship.
Quick answers
Who was awarded contract SPE2DR26F6W9V?
SPE2DR26F6W9V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F6W9V worth?
The government has obligated $6,762 on SPE2DR26F6W9V.
Is contract SPE2DR26F6W9V an order under another contract?
Yes. SPE2DR26F6W9V is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6W9V competed?
The extent of competition for SPE2DR26F6W9V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award